Haemonetics SmartSuction technology:
This article was originally published in Clinica
Haemonetics has launched in the US an automated surgical suction device that it claims enhances a surgeon's ability to clear fluids from the surgical field by providing high air flow and self-regulating suction. The SmartSuction Solo system, which received 510(k) clearance last month, is the first product that Haemonetics will sell into the general surgery market, expanding its market opportunity by an incremental $240m, says the Braintree, Massachusetts company. It is the third system developed by the firm under its SmartSuction family of products, and marks a milestone in Haemonetics' efforts to expand from a surgical blood salvage company into a broader blood management company, the firm adds. The company acquired the technology from Harvest Technologies in 2004 (see Clinica No 1123 p 14).
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.